Fresenius | FRE - Gross Profit On Sales



Fresenius reported EUR1.46B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Akzo Nobel EUR 1.04B 10M Jun/2025
Alcon AG USD 1.39B 5M Jun/2025
AstraZeneca USD 11.98B 637M Jun/2025
BASF EUR 4.18B 675M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
DaVita Healthcare Partners USD 943.28M 40.59M Jun/2025
Demant DKK 8.55B 33M Jun/2025
E.ON EUR 5.3B 169M Jun/2025
Essilor EUR 8.84B 687M Jun/2025
Fresenius EUR 1.46B 47M Jun/2025
Fresenius Medical Care EUR 1.22B 31M Jun/2025
Getinge SEK 5.05B 1.5B Dec/2024
Givaudan CHF 823M 575M Jun/2024
GlaxoSmithKline GBP 5.82B 229M Jun/2025
GN Store Nord DKK 2.31B 123M Jun/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 692M 64M Dec/2024
Lonza CHF 1.04B 72M Dec/2024
Merck EUR 3.03B 118M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Philips EUR 2.01B 162M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
RWE EUR 1.54B 2.36B Mar/2025
Sanofi EUR 7.74B 26M Jun/2025
Smith & Nephew USD 2.09B 19M Jun/2025